Chester County News and Community Website
PHILADELPHIA, PA — Carisma Therapeutics Inc. (OTCID: CARM) plans to voluntarily delist its common stock from the Nasdaq Stock Market and deregister its shares with federal regulators, accelerating its withdrawal …
Carisma’s Swift Exit From Nasdaq Signals a Dramatic Corporate Retreat Read More
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) announced that its common stock has been approved for listing on the Nasdaq Capital Market. Trading began today, July 24, under the existing …
Acorn Energy to Begin Trading on Nasdaq as Company Eyes Strong Growth Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has received a notice from the New York Stock Exchange (NYSE) regarding its non-compliance with continued listing standards under Section 802.01B of the …
Annovis Bio Receives Non-Compliance Notice from NYSE Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced it has successfully regained compliance with The Nasdaq Stock Market LLC’s minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This ensures …
Windtree Therapeutics Regains Nasdaq Compliance Read More
QUAKERTOWN, PA — QNB Corp. (OTCQX: QNBC), the parent company of QNB Bank, has announced its transition to the OTCQX® Best Market from the Pink® market. The move represents a significant …
QNB Corp. Joins OTCQX Best Market Read More
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) has announced its successful return to compliance with Nasdaq’s minimum stockholders’ equity requirements, ensuring the continuation of its listing on the Nasdaq Capital …
Traws Pharma Regains Nasdaq Compliance, Strengthening Position for 2025 Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) announced that its common stock is set to be delisted from The Nasdaq Stock Market LLC following a decision by the Nasdaq Hearings Panel …
Trevena, Inc. Faces Delisting from Nasdaq Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. announced it has regained compliance with Nasdaq’s minimum bid price requirement as of July 24, 2024. This achievement follows a formal notice from Nasdaq’s …
Virpax Pharmaceuticals Regains Nasdaq Compliance Read More